Contract A207_PO-0481782

New England Biolabs Inc has been awarded a contract by the University of Virginia, located in Virginia, effective September 18, 2026. The contract represents a cumulative value of $160 and encompasses the procurement of DpnI enzymatic reagents. The deliverable consists of two units of DpnI (1,000 units per unit) at a unit price of $80 each, to be delivered to Jennifer L Bryant. DpnI is a restriction endonuclease enzyme commonly utilized in molecular biology applications for the selective degradation of methylated deoxyribonucleic acid.

The contract structure indicates a straightforward transactional purchase order arrangement with a single line item for the specified enzyme product. While the contract award date is documented as September 18, 2026, no explicit contract performance period or delivery deadline is provided in the available documentation. The University of Virginia serves as the contracting organization and designated point of delivery for this procurement.